Cargando…
Phosphate and fibroblast growth factor 23 in diabetes
Diabetes is associated with a strongly elevated risk of cardiovascular disease, which is even more pronounced in patients with diabetic nephropathy. Currently available guideline-based efforts to correct traditional risk factors are only partly able to attenuate this risk, underlining the urge to id...
Autores principales: | van der Vaart, Amarens, Yeung, Stanley M.H., van Dijk, Peter R., Bakker, Stephan J.L., de Borst, Martin H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302806/ https://www.ncbi.nlm.nih.gov/pubmed/34283205 http://dx.doi.org/10.1042/CS20201290 |
Ejemplares similares
-
Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies
por: van der Vaart, Amarens, et al.
Publicado: (2023) -
Inflammation: a putative link between phosphate metabolism and cardiovascular disease
por: Voelkl, Jakob, et al.
Publicado: (2021) -
Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage
por: Mirabito Colafella, Katrina M., et al.
Publicado: (2022) -
Plasma phosphate and all-cause mortality in individuals with and without type 2 diabetes: the Dutch population-based lifelines cohort study
por: van der Vaart, Amarens, et al.
Publicado: (2022) -
MicroRNAs targeting VEGF are related to vascular dysfunction in preeclampsia
por: Witvrouwen, Isabel, et al.
Publicado: (2021)